Nelson lecturer to discuss the potential of HIV vaccines
Professor Sir Andrew McMichael of the Weatherall Institute of Molecular Medicine at the University of Oxford will be the UC Davis School of Medicine’s 2013 Nelson Scientific Lecturer.
Widely recognized as an expert in the molecular events involved in viral infection, McMichael is currently testing a series of T-cell boosting vaccines to determine if they can replace traditional drug treatments in preventing or controlling human immunodeficiency virus (HIV). He was knighted for his service to medical science in the United Kingdom, where he is also a fellow of both the Royal Society and the Academy of Medical Sciences.
There are two opportunities to hear McMichael’s lecture, which is titled “T-cell immune responses against HIV-1: Can they be harnessed by vaccines?” He will speak on Wednesday, Feb. 6, at noon in the auditorium of the Genome and Biomedical Sciences Facility, 451 Health Sciences Drive, at UC Davis, and at 5 p.m. in the Matsui Lecture Hall of the Education Building, 4610 X St., at UC Davis Health System in Sacramento.
Both lectures are free and open to the public. To reserve a seat, e-mail firstname.lastname@example.org or call 916-734-9101.
The Nelson Lectureship was established to honor the legacy of Woodland, Calif., pioneers Camillus and Elizabeth Nelson and to bring thought-provoking speakers in medicine and science to the region.
The UC Davis School of Medicine is among the nation's leading medical schools, recognized for its research and primary-care programs. The school offers fully accredited master's degree programs in public health and in informatics, and its combined M.D.-Ph.D. program is training the next generation of physician-scientists to conduct high-impact research and translate discoveries into better clinical care. Along with being a recognized leader in medical research, the school is committed to serving underserved communities and advancing rural health. For more information, visit the UC Davis School of Medicine website.